Revlimid 10MG, 15MG, 25MG
Ended Awarded
- Contract number
- 36C24526N0314
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $50,133
Award facts
- Contract value 100% obligated
- $50,133.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Memphis, TN 38141, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company has been awarded a delivery order valued at $50,133.22 by Veterans Integrated Service Network 5 (VISN 5) under the Department of Veterans Affairs for the supply of REVLIMID in 10mg, 15mg, and 25mg formulations. The award, issued on February 11, 2026, represents a firm fixed-price delivery order with a completion date of February 13, 2026, and carries no set-aside designation. This delivery order is issued under Bristol-Myers Squibb's Federal Supply Schedule contract (36F79724D0101) for Pharmaceuticals and Drugs (FSS-61-IB), a multiple-award indefinite delivery/indefinite quantity contract with the VA that carries a ceiling value of $12.3 billion and extends through April 30, 2029.
REVLIMID (lenalidomide) is a critical immunomodulatory agent used in the treatment of multiple myeloma, myelodysplastic syndromes, and other hematologic malignancies, making this procurement consistent with the VA's mission to provide advanced oncology therapies to eligible veterans. Bristol-Myers Squibb, a global biopharmaceutical manufacturer headquartered in Lawrenceville, New Jersey, serves as a primary supplier of specialized oncology and cell therapy products to the VA healthcare system. The performance location for this delivery order is Memphis, Tennessee, and the company has received numerous similar delivery orders across multiple Veterans Integrated Service Networks since 2022, reflecting sustained demand for its specialized pharmaceutical products within the Veterans Health Administration network.
Quick answers
Who was awarded contract 36C24526N0314?
36C24526N0314 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 11, 2026.
How much is contract 36C24526N0314 worth?
The government has obligated $50,133 on 36C24526N0314.
Is contract 36C24526N0314 an order under another contract?
Yes. 36C24526N0314 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0314 competed?
The extent of competition for 36C24526N0314 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award